These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9533484)

  • 21. Playing "kick the FDA"--risk-free to players but hazardous to public health.
    Wood AJ
    N Engl J Med; 2008 Apr; 358(17):1774-5. PubMed ID: 18434649
    [No Abstract]   [Full Text] [Related]  

  • 22. Family Smoking Prevention And Tobacco Control Act: banning outdoor tobacco advertising near schools and playgrounds.
    Luke DA; Ribisl KM; Smith C; Sorg AA
    Am J Prev Med; 2011 Mar; 40(3):295-302. PubMed ID: 21335260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible association between isotretinoin and inflammatory bowel disease.
    Reddy D; Siegel CA; Sands BE; Kane S
    Am J Gastroenterol; 2006 Jul; 101(7):1569-73. PubMed ID: 16863562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug firm was aware of deaths, probe says.
    Mintz M
    Washington Post; 1982 Dec; ():A2. PubMed ID: 11647760
    [No Abstract]   [Full Text] [Related]  

  • 26. Government tobacco regulation: opportunity for change.
    Myers ML
    Lancet; 2006 Jul; 368(9532):268-70. PubMed ID: 16860682
    [No Abstract]   [Full Text] [Related]  

  • 27. Pushing drugs to doctors.
    Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
    [No Abstract]   [Full Text] [Related]  

  • 28. Imperial Tobacco fails to block ban on cigarette displays in Scotland.
    Christie B
    BMJ; 2012 Feb; 344():e952. PubMed ID: 22315251
    [No Abstract]   [Full Text] [Related]  

  • 29. The goals of FDA regulation and the challenges of meeting them.
    Tyler RS
    Health Matrix Clevel; 2013; 22(2):423-31. PubMed ID: 23668096
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental drugs: more of them, but they're no longer free.
    Caplan J
    Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
    [No Abstract]   [Full Text] [Related]  

  • 31. Ensuring scientific integrity in research: aspects of fairness and justice.
    Green HP
    Account Res; 1993; 3(2-3):209-13. PubMed ID: 11652295
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA regulation of prescription drug advertising.
    Peck CC; Rheinstein PH
    JAMA; 1990 Nov; 264(18):2424-5. PubMed ID: 2232001
    [No Abstract]   [Full Text] [Related]  

  • 33. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 34. Tobacco product regulation--a public health approach.
    Deyton L; Sharfstein J; Hamburg M
    N Engl J Med; 2010 May; 362(19):1753-6. PubMed ID: 20410498
    [No Abstract]   [Full Text] [Related]  

  • 35. Pitching doctors.
    Wilkes MS; Shuchman M
    N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
    [No Abstract]   [Full Text] [Related]  

  • 36. Two new efforts to inform patients about drugs launch a post-PPI era.
    Med World News; 1982 Sep; 23(20):8-9. PubMed ID: 11645760
    [No Abstract]   [Full Text] [Related]  

  • 37. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information.
    Samuels A
    Account Res; 1999; 6(4):259-310. PubMed ID: 11657840
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA regulation of tobacco--pitfalls and possibilities.
    Brandt AM
    N Engl J Med; 2008 Jul; 359(5):445-8. PubMed ID: 18663229
    [No Abstract]   [Full Text] [Related]  

  • 39. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Sep; 278(10):805. PubMed ID: 9293976
    [No Abstract]   [Full Text] [Related]  

  • 40. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.